Vimarsana
Biggest News Aggregation in the World

Page 2 - Compugen Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Ltd Today - Breaking & Trending Today

Why CFO turnover at public companies just hit a 3-year high - Vimarsana News

Why CFO turnover at public companies just hit a 3-year high

Part of the reason for the CFO shakeup is more finance chiefs ascending to the top spot.

Compugen : To Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 - Vimarsana News

Compugen : To Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024

FOR IMMEDIATE RELEASE: Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in ...

Analyzing Compugen (NASDAQ:CGEN) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Vimarsana News

Analyzing Compugen (NASDAQ:CGEN) & PharmaCyte Biotech (OTCMKTS:PMCBD)

PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) and Compugen (NASDAQ:CGEN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Profitability This table compares PharmaCyte Biotech and Compugen’s […]

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 - Vimarsana News

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy -March 11, 2024 at 07:08 am EDT - Vimarsana News

Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy -March 11, 2024 at 07:08 am EDT

FOR IMMEDIATE RELEASE: Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy ...